Old Web
English
Sign In
Acemap
>
Paper
>
PD-0806 HDR-BT + SBRT for prostate cancer. QoL and toxicity analysis in a prospective phase II trial.
PD-0806 HDR-BT + SBRT for prostate cancer. QoL and toxicity analysis in a prospective phase II trial.
2021
D Büchser
A. Bilbal
E. Mayrata
F. Pérez
José María Espinosa
I. Valverde
B. Santos
Francisco Casquero
A. Gómez de Iturriaga
Keywords:
Prostate cancer
Oncology
Toxicity
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]